Emergency rooms could be key to ending HIV: new study tests simple PrEP strategies

NCT ID NCT05588193

Ongoing Prevention Sponsor: Albert Einstein College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two low-burden strategies to increase HIV PrEP use among emergency department patients seeking care for sexual health issues. One strategy involves follow-up outreach after the visit, while the other offers a tele-sexual health visit during the ER stay. The goal is to see which approach helps more at-risk patients start PrEP, a daily pill that prevents HIV.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral interventions (post-visit outreach and tele-sexual health visit)
What this could lead to: If successful, this could provide simple, effective ways to start HIV prevention medication for people who visit emergency rooms for sexual health concerns, helping reduce new HIV infections.
What could go wrong: This is an implementation study, not a drug trial, so it tests how to deliver existing prevention tools rather than a new cure. Results may vary across different communities and emergency departments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

City University of New York - Hunter College

New York, New York, 10031, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.